Friday, May 28, 2021
Top Story on Newswise: Mild COVID-19 induces lasting antibody protection
One of Newswise’s top stories is about how people with mild covid-19 have long-lasting antibody protection.
Ali Ellebedy from the Washington University School of Medicine in St. Louis found that patients had cells in their bone marrow that offered protection for 11-12 months after infection.
He took bone marrow samples from a group of people 7-8 months after they had a mild covid19 infection and then again after another four months.
This antibody response could continue for a lifetime. Ellebedy and his colleagues are now looking at the antibody response after vaccination.
I am Jessica Johnson from Newswise, have a great day!
You can check out our video of last week’s best articles on Newswise here.